Lista de obras - Gabriella Scarlatti - Dominio Público Uruguay

A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2.

artículo científico publicado en 2011

A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion

artículo científico publicado en 2013

A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load

artículo científico publicado en 2008

Analysis of the HIV-1 Envelope V3-Loop Sequences from Ten Mother-Child Pairs

article

Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays

scientific article published on 01 June 1993

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele ⬇️

artículo científico publicado el 4 de agosto de 1997

Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection

artículo científico publicado en 1993

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition

artículo científico publicado en 2014

B-cell subset alterations and correlated factors in HIV-1 infection

artículo científico publicado en 2013

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

artículo científico publicado en 2015

Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.

artículo científico publicado en 2007

Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein

artículo científico publicado en 2014

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

artículo científico publicado en 2011

C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.

artículo científico publicado en 1997

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate

artículo científico publicado en 2013

Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent

artículo científico publicado en 2014

Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants

article

Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission ⬇️

artículo científico publicado el 1 de enero de 1993

Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41

artículo científico publicado en 2010

Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA) ⬇️

artículo científico publicado el 1 de marzo de 1992

Determination of HIV-1 co-receptor usage.

artículo científico publicado en 2014

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

artículo científico publicado en 2015

Early detection of IgA specific antibodies in HIV-1 infected children by peptide-ELISA and peptide time-resolved fluoro-immunoassay

article

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies.

artículo científico publicado en 2018

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis

artículo científico publicado en 2003

Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice.

artículo científico publicado en 1993

Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children ⬇️

artículo científico publicado el 23 de octubre de 2010

HIV type 1 chemokine receptor usage in mother-to-child transmission.

artículo científico publicado en 2001

HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infection

artículo científico publicado en 2011

HIV-1 infection: the role of the gastrointestinal tract.

artículo científico

HIV-1 isolation from infected peripheral blood mononuclear cells.

artículo científico publicado en 2014

HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children

artículo científico publicado en 2008

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

artículo científico publicado en 2015

HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

artículo científico publicado en 2017

HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes.

artículo científico publicado en 2009

Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.

artículo científico publicado en 2011

Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model

artículo científico publicado en 2017

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

artículo científico publicado en 1997

Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes.

artículo científico publicado en 2006

International network for comparison of HIV neutralization assays: the NeutNet report

artículo científico publicado en 2009

Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS

article

Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.

artículo científico publicado en 2017

Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon

artículo científico publicado en 2003

Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry

artículo científico publicado en 2017

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization.

artículo científico publicado en 2012

Occupational HIV Infection in a Research Laboratory With Unknown Mode of Transmission: A Case Report

artículo científico publicado en 2016

Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques

artículo científico publicado en 2013

Oral CCR5 inhibitors: will they make it through?

artículo científico publicado en 2006

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

article

P04-20. Humoral immune response in acute HIV-1 infection.

artículo científico publicado en 2009

P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression

article

Paediatric HIV infection

artículo científico publicado en 1996

Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

artículo científico publicado en 2022

Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression

artículo científico publicado en 2009

Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children

article

Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection

artículo científico publicado en 2002

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

artículo científico publicado en 2010

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.

artículo científico publicado en 2012

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.

artículo científico publicado en 2011

Recent progress in immune-based interventions to prevent HIV-1 transmission to children

artículo científico publicado en 2017

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model

artículo científico publicado en 2013

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

artículo científico publicado en 2014

Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children

article

Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates

artículo científico publicado en 2016

The role of virologic and immunologic factors in mother-to-child transmission of HIV-1

scientific article published on 01 September 1997

Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)

artículo científico publicado en 2013

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

artículo científico publicado en 2016

Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.

artículo científico publicado en 1993

Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus

artículo científico publicado el 1 de octubre de 1992

Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations

artículo científico publicado en 2008

Lista de obras de Gabriella Scarlatti

A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2.

A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion

A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load

Analysis of the HIV-1 Envelope V3-Loop Sequences from Ten Mother-Child Pairs

Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele ⬇️

Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition

B-cell subset alterations and correlated factors in HIV-1 infection

Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets

Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression.

Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate

Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent

Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants

Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission ⬇️

Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41

Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA) ⬇️

Determination of HIV-1 co-receptor usage.

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.

Early detection of IgA specific antibodies in HIV-1 infected children by peptide-ELISA and peptide time-resolved fluoro-immunoassay

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies.

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis

Epitope specificity, antibody-dependent cellular cytotoxicity, and neutralizing activity of antibodies to human immunodeficiency virus type 1 in autoimmune MRL/lpr mice.

Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children ⬇️

HIV type 1 chemokine receptor usage in mother-to-child transmission.

HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infection

HIV-1 infection: the role of the gastrointestinal tract.

HIV-1 isolation from infected peripheral blood mononuclear cells.

HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes.

Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.

Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes.

International network for comparison of HIV neutralization assays: the NeutNet report

Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS

Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.

Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon

Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization.

Occupational HIV Infection in a Research Laboratory With Unknown Mode of Transmission: A Case Report

Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques

Oral CCR5 inhibitors: will they make it through?

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

P04-20. Humoral immune response in acute HIV-1 infection.

P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression

Paediatric HIV infection

Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression

Polymorphism at codon 54 of mannose-binding protein gene influences AIDS progression but not HIV infection in exposed children

Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.

Recent progress in immune-based interventions to prevent HIV-1 transmission to children

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children

Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates

The role of virologic and immunologic factors in mother-to-child transmission of HIV-1

Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.

Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus

Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations